Chargement en cours...
Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity
AIMS: Doxorubicin (DOX) is a widely used and effective anti-cancer therapeutic. DOX treatment is associated with both acute and late onset cardiotoxicity, limiting its overall efficacy. Here, the impact of cardiomyocyte cell cycle activation was examined in a juvenile model featuring aspects of acut...
Enregistré dans:
| Publié dans: | Cardiovasc Res |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452322/ https://ncbi.nlm.nih.gov/pubmed/30423020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvy273 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|